EBT
LLY icon

Enterprise Bank & Trust’s Eli Lilly LLY Stock Holding History

Enterprise Bank & Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$4.52M Sell
5,795
-14
-0.2% -$10.9K 1.69% 12
2025
Q1 		$4.8M Sell
5,809
-620
-10% -$516K 1.85% 13
2024
Q4 		$4.96M Sell
6,429
-246
-4% -$204K 1.63% 15
2024
Q3 		$5.91M Sell
6,675
-283
-4% -$254K 1.91% 14
2024
Q2 		$6.3M Sell
6,958
-376
-5% -$301K 2.15% 11
2024
Q1 		$5.71M Sell
7,334
-980
-12% -$697K 1.96% 13
2023
Q4 		$4.85M Sell
8,314
-747
-8% -$436K 1.73% 14
2023
Q3 		$4.87M Sell
9,061
-299
-3% -$154K 2.01% 11
2023
Q2 		$4.39M Sell
9,360
-293
-3% -$123K 1.68% 12
2023
Q1 		$3.32M Sell
9,653
-454
-4% -$153K 1.43% 18
2022
Q4 		$3.7M Sell
10,107
-48
-0.5% -$17K 1.75% 13
2022
Q3 		$3.28M Sell
10,155
-290
-3% -$91.9K 1.71% 13
2022
Q2 		$3.39M Sell
10,445
-1,485
-12% -$446K 1.53% 15
2022
Q1 		$3.42M Sell
11,930
-738
-6% -$190K 1.34% 22
2021
Q4 		$3.5M Sell
12,668
-27
-0.2% -$6.84K 1.22% 31
2021
Q3 		$2.93M Sell
12,695
-264
-2% -$65.2K 1.16% 32
2021
Q2 		$2.97M Sell
12,959
-1
-0% -$201 1.17% 33
2021
Q1 		$2.42M Sell
12,960
-32
-0.2% -$6.26K 1.02% 37
2020
Q4 		$2.19M Buy
12,992
+1,007
+8% +$150K 0.94% 39
2020
Q3 		$1.77M Sell
11,985
-217
-2% -$33.6K 0.83% 42
2020
Q2 		$2M Buy
12,202
+2,004
+20% +$308K 1% 34
2020
Q1 		$1.42M Sell
10,198
-358
-3% -$49.2K 0.84% 41
2019
Q4 		$1.39M Buy
10,556
+272
+3% +$31.5K 0.62% 50
2019
Q3 		$1.15M Buy
10,284
+7,857
+324% +$875K 0.56% 51
2019
Q2 		$269K Buy
2,427
+180
+8% +$21.2K 0.14% 74
2019
Q1 		$292K Buy
+2,247
New +$273K 0.12% 86

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Enterprise Bank & Trust's LLY Position: Q2 2025 in Review

Enterprise Bank & Trust reduced its Eli Lilly (LLY) stake by 0.24% in Q2 2025, selling an estimated $10.9K and leaving 5,795 shares worth $4.52M. The position accounts for 1.69% of the portfolio, ranked #12.

Enterprise Bank & Trust first reported a position in LLY in Q1 2019 and has held it in 26 quarters since. The position peaked at $6.3M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Enterprise Bank & Trust held 5,795 shares of Eli Lilly worth $4.52M as of Q2 2025.
  • Enterprise Bank & Trust sold 14 Eli Lilly shares in Q2 2025, an estimated $10.9K.
  • Eli Lilly made up 1.69% of Enterprise Bank & Trust's portfolio in Q2 2025, its #12 holding.
  • Enterprise Bank & Trust first reported a position in Eli Lilly in Q1 2019 and has held it in 26 quarters since.
  • Enterprise Bank & Trust's Eli Lilly position peaked at $6.3M in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Enterprise Bank & Trust's 13F filing for Q2 2025, filed 7 Jul 2025.